Search results for "LSA"

showing 10 items of 832 documents

Global injury morbidity and mortality from 1990 to 2017 : results from the Global Burden of Disease Study 2017

2020

Publisher's version (útgefin grein)

DánarmeinFötlunDánartíðniLífslíkurLife expectancy1106 Human Movement and Sports Sciencesburden of diseaseGlobal HealthGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal healthMedicineLIFE EXPECTANCY030212 general & internal medicine1506POPULATIONCause of deathOriginal ResearchRISKeducation.field_of_studyGlobal disease burdensInjuriesSjúkdómarIncidence (epidemiology)IncidencePopulation healthBurden of diseaseGlobalglobal3142 Public health care science environmental and occupational health3. Good healthDescriptive epidemiologyLýðheilsaQuality-Adjusted Life YearsPublic HealthTERRITORIESdescriptive epidemiologyHumanPopulation195 COUNTRIESPopulation healthCause of deathburden of disease; descriptive epidemiology; global; Humans; Incidence; Life Expectancy; Morbidity; Quality-Adjusted Life Years; Global Burden of Disease; Global Health; Wounds and Injuries1117 Public Health and Health Services03 medical and health sciencesAGESYSTEMATIC ANALYSISHumansMortalityeducationDisabilitySEX-SPECIFIC MORTALITYbusiness.industryFaraldsfræðiDISABILITYPublic Health Environmental and Occupational HealthQuality-adjusted life yearYears of potential life lostÁverkar1701 PsychologyLife expectancyWounds and InjuriesHuman medicineMorbiditybusiness030217 neurology & neurosurgeryDemography
researchProduct

Carga global, regional y nacional de neurológicas. Desórdenes, 1990-2016: un análisis sistemático para el Global Estudio de la carga de enfermedad 20…

2019

Publisher´s version (útgefin grein).

DánarmeinMaleEpidemiologyDiseasesMalalties cerebralsGlobal Burden of DiseaseDisability Evaluation0302 clinical medicineCase fatality ratePsychologyKonurCause of deathAged 80 and overeducation.field_of_studyIncidenceMenTaugavísindiddc:3. Good healthSálfræðiWorld healthMuerteNeurologyGBD 2016 Neurology CollaboratorsBrain diseasesQuality-Adjusted Life YearsAlzheimer diseaseCarga global de enfermedadesNervous systemmedicine.medical_specialtyGlobal burden of diseasesLífsgæðiArticle03 medical and health sciencesHealth SciencesHumansWomeneducationTrastornos neurológicosVLAGAgedScience & Technology3112 NeurosciencesGlobal Burden of Diseases030104 developmental biologyYears of potential life lostΕπιστήμες ΥγείαςDementiaHuman medicineNeurosciences & NeurologyNeurology (clinical)Clinical Medicine1109 NeurosciencesNeurological disorders030217 neurology & neurosurgerydementiaRC0301 basic medicinePediatricsDánartíðniNutrition and Disease3124 Neurology and psychiatryDisease StudyTaugasjúkdómarRisk FactorsVoeding en ZiekteCause of DeathGlobal healthPrevalenceNeurological disorders; Global Burden of DiseasesCauses of deathPublic healthMortality rateMental DisordersAge FactorsPublic Health Global Health Social Medicine and EpidemiologyMiddle Agedneurologic diseaseDeathLýðheilsaFemaleLife Sciences & BiomedicineQuality of lifeAdultPopulationClinical NeurologySex FactorsmedicineLife ScienceDisability-adjusted life year:Medicine [Science]MortalityPsychiatryDisease burdenNeurology & Neurosurgeryburden of neurological disordersFaraldsfræðibusiness.industryKlinisk medicinCauses de la mort1103 Clinical SciencesFolkhälsovetenskap global hälsa socialmedicin och epidemiologiSocioeconomic FactorsKarlarglobal disease burdenNervous System DiseasesCause of death/trendsbusiness
researchProduct

"Table 1" of "First measurement of f2-prime (1525) production in Z0 hadronic decays"

1996

SIG in (1/SIG) is the total hadronic cross section.

E+ E- --> F2PRIME(1525) XInclusiveSingle Differential Cross SectionInformationSystems_MODELSANDPRINCIPLESComputingMilieux_THECOMPUTINGPROFESSIONGeneralLiterature_INTRODUCTORYANDSURVEYInformationSystems_INFORMATIONINTERFACESANDPRESENTATION(e.g.HCI)E+ E- Scattering91.2InformationSystems_MISCELLANEOUSDSIG/DX
researchProduct

Suppressive Efficacy by a Commercially Available Blue Lens on PPR in 610 Photosensitive Epilepsy Patients

2006

Purpose Photosensitivity can represent a serious problem in epilepsy patients, also because pharmacologic treatment is often ineffective. Nonpharmacologic treatment using blue sunglasses is effective and safe in controlling photosensitivity, but large series of patients have never been studied. Methods This multicenter study was conducted in 12 epilepsy centers in northern, central, southern, and insular Italy. A commercially available lens, named Z1, obtained in a previous trial, was used to test consecutively enrolled pediatric and adult epilepsy patients with photosensitivity. Only type 4 photosensitivity (photoparoxysmal response, PPR) was considered in the study. A standardized method …

EPILEPSY-PHOTOSENSITIVE-BLUE GLASSES-NONPHARMACOLOGICAdultMalemedicine.medical_specialtyAdolescentEpilepsy ReflexPharmacological treatmentCentral nervous system diseaseEpilepsyPhotosensitive epilepsyInternal medicineFemale patientmedicineHumansPractice Patterns Physicians'ChildAgedbusiness.industryVideotape RecordingLarge seriesElectroencephalographyMiddle Agedmedicine.diseaseTREATMENT-PHOTOPAROXYSMAL RESPONSE-PPRSurgeryClinical trialTreatment OutcomeItalyNeurologyMulticenter studyChild PreschoolAnticonvulsantsFemaleNeurology (clinical)PHOTOSENSITIVEEye Protective DevicesbusinessColor PerceptionPhotic StimulationEpilepsia
researchProduct

Evaluation of the LSA-SAF gross primary production product derived from SEVIRI/MSG data (MGPP)

2020

The objective of this study is to describe a completely new 10-day gross primary production (GPP) product (MGPP LSA-411) based on data from the geostationary SEVIRI/MSG satellite within the LSA SAF (Land Surface Analysis SAF) as part of the SAF (Satellite Application Facility) network of EUMETSAT. The methodology relies on the Monteith approach. It considers that GPP is proportional to the absorbed photosynthetically active radiation APAR and the proportionality factor is known as the light use efficiency ε. A parameterization of this factor is proposed as the product of a εmax, corresponding to the canopy functioning under optimal conditions, and a coefficient quantifying the reduction of …

Earth observation010504 meteorology & atmospheric sciencesWater stressSEVIRI/MSG0211 other engineering and technologiesEddy covariance02 engineering and technology01 natural sciences114 Physical sciencesApproximation errorMGPP10-dayComputers in Earth SciencesEngineering (miscellaneous)021101 geological & geomatics engineering0105 earth and related environmental sciencesRemote sensingPrimary production15. Life on landAtomic and Molecular Physics and OpticsComputer Science ApplicationsPhotosynthetically active radiationProduct (mathematics)Geostationary orbitEnvironmental scienceLSA SAFSatelliteGPPLight-use efficiency
researchProduct

Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry

2022

Aims: Sacubitril/valsartan has changed the treatment of heart failure with reduced ejection fraction (HFrEF), due to the positive effects on morbidity and mortality, partly mediated by left ventricular (LV) reverse remodelling (LVRR). The aim of this multicenter study was to identify echocardiographic predictors of LVRR after sacubitril/valsartan administration. Methods and results: Patients with HFrEF requiring therapy with sacubitril/valsartan from 13 Italian centres were included. Echocardiographic parameters including LV global longitudinal strain (GLS) and global peak atrial longitudinal strain by speckle tracking echocardiography were measured to find the predictors of LVRR [= LV end-…

EchocardiographyUltrasoundRemodellingHeart failureSacubitril/valsartanBiomarkers Cardiovascular disease Echocardiography Heart failure Imaging Remodelling Sacubitril/valsartan Speckle tracking UltrasoundCardiology and Cardiovascular MedicineCardiovascular diseaseBiomarkers; Cardiovascular disease; Echocardiography; Heart failure; Imaging; Remodelling; Sacubitril/valsartan; Speckle tracking; Ultrasound.BiomarkersImagingSpeckle tracking
researchProduct

Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Devel…

2020

BACKGROUND: Sustainable Development Goal (SDG) 3 aims to "ensure healthy lives and promote well-being for all at all ages". While a substantial effort has been made to quantify progress towards SDG3, less research has focused on tracking spending towards this goal. We used spending estimates to measure progress in financing the priority areas of SDG3, examine the association between outcomes and financing, and identify where resource gains are most needed to achieve the SDG3 indicators for which data are available. METHODS: We estimated domestic health spending, disaggregated by source (government, out-of-pocket, and prepaid private) from 1995 to 2017 for 195 countries and territories. For …

Economic growthFinancing GovernmentPsychological interventionHIV Infectionsburden of disease030204 cardiovascular system & hematologyDISEASEALLOCATION0302 clinical medicineRA0421RA0421 Public health. Hygiene. Preventive MedicineSustainable developmentGlobal healthhealth economicsHealthcare FinancingHIV Infection030212 general & internal medicine10. No inequality11 Medical and Health SciencesDALYHealthy lives1. No povertyPublic Health Global Health Social Medicine and Epidemiology3rd-DASGeneral MedicineSustainable Development3. Good healthtuberculosisIMPOVERISHMENTTERRITORIESFinancingHumanFinancing PersonalResource (biology)Tuberculosi195 COUNTRIESDeveloping Countrie03 medical and health sciencesSDG 3 - Good Health and Well-beingAcquired immunodeficiency syndrome (AIDS)General & Internal MedicineSYSTEMATIC ANALYSISmedicineHumansBurden HIV/AIDS tubercolosis malariaHuman resourcesDeveloping CountriesSustainable developmentGovernmentAcquired Immunodeficiency SyndromeHealth economicsbusiness.industryDISABILITYCATASTROPHEGlobal Burden of Disease Health Financing Collaborator NetworkGLOBAL BURDENmedicine.diseaseMalariaSDG; health sector spending; development assistant for health.Health ExpenditureFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineNAHealth ExpendituresbusinessEXPENDITURE
researchProduct

L’immaginario custodito. Catalogo delle raccolte 1-2-3 dell’Archivio etnofonico del Folkstudio

2009

The essay contains the catalog of sound recordings relating to field surveys conducted from 1966 to 1970, constituting the first collections of the Ethnophonic Archive of the Folkstudio of Palermo, formed thanks to the initial donation of Elsa Guggino and implemented with the researches of his students.

Ethnophonic Archive Folkstudio of Palermo Elsa Guggino
researchProduct

Se alarga la sombra del 11-S

2004

FBIVidal-Beneyto JoséConspiraciónSombras11-STerrorismoIrresponsabilidadClanBanquieroPoder políticoBolsa de Nueva YorkPublicaciones: Obra periodística: Columnas y artículos de opiniónPolítica exteriorCIAInteligencia paquistalíAdministraciónAtentadosBushTorres GemelasAltas instanciasEstados UnidosMovilización bélicaResponsablesInformeChomskyContradiccionesComisión NacionalIncógnitasCheney
researchProduct

Constraints on ultra-high-energy cosmic ray sources from a search for neutrinos above 10 PeV with IceCube

2016

We report constraints on the sources of ultra-high-energy cosmic ray (UHECR) above $10^{9}$ GeV, based on an analysis of seven years of IceCube data. This analysis efficiently selects very high energy neutrino-induced events which have deposited energies from $\sim 10^6$ GeV to above $10^{11}$ GeV. Two neutrino-induced events with an estimated deposited energy of $(2.6 \pm 0.3) \times 10^6$ GeV, the highest neutrino energies observed so far, and $(7.7 \pm 2.0) \times 10^5$ GeV were detected. The atmospheric background-only hypothesis of detecting these events is rejected at 3.6$\sigma$. The hypothesis that the observed events are of cosmogenic origin is also rejected at $>$99% CL because of…

FLUXSELECTIONFERMI-LATActive galactic nucleusCosmology and Nongalactic Astrophysics (astro-ph.CO)Astrophysics::High Energy Astrophysical PhenomenaGeneral Physics and AstronomyFOS: Physical sciencesCosmic rayAstrophysicsParameter space7. Clean energy01 natural sciencesCOSMOGENIC NEUTRINOS; TRACK RECONSTRUCTION; FERMI-LAT; BURSTS; SPECTRUM; MODEL; FLUX; TELESCOPES; SELECTION; EMISSIONPulsar0103 physical sciencesTRACK RECONSTRUCTIONBURSTSddc:550Ultrahigh energy010303 astronomy & astrophysicsPhysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)SPECTRUM010308 nuclear & particles physicsStar formationCOSMOGENIC NEUTRINOSAstrophysics::Instrumentation and Methods for AstrophysicsAstronomyMODELPhysics and Astronomy13. Climate actionTELESCOPESHigh Energy Physics::ExperimentNeutrinoAstrophysics - High Energy Astrophysical PhenomenaEMISSIONEnergy (signal processing)Astrophysics - Cosmology and Nongalactic Astrophysics
researchProduct